Caelum Biosciences Overview

  • Founded
  • 2015

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $150M

Caelum Biosciences General Information

Description

Operator of a clinical-stage biotechnology comapny intended to develop treatments for rare and life-threatening conditions. The company is engaged in development of antibodies that work to break up pre-existing amyloid in tissues and to help the body's immune system remove the deleterious material, enabling patients with a greater chance to be a safe, receive well-tolerated therapy that promotes amyloid resolution and improve organ responses.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Primary Office
  • Rutgers Ecocomplex
  • 1200 Florence Road
  • Bordentown, NJ 08505
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Caelum Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 06-Oct-2021 $150M 000.00 00000 Completed Clinical Trials - Phase 3
1. Early Stage VC 30-Jan-2019 000.00 000.00 Completed Clinical Trials - Phase 3
To view Caelum Biosciences’s complete valuation and funding history, request access »

Caelum Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage biotechnology comapny intended to develop treatments for rare and life-threatening conditio
Biotechnology
Bordentown, NJ
000.00
0000 0000-00-00
000000&0 000.00

000000

onsequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
0000000000000
Redwood City, CA
000 As of 0000
00000
00000000000 00000

000000

sse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat no
0000 000000000
Niel, Belgium
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Caelum Biosciences Competitors (65)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adverum Biotechnologies Formerly VC-backed Redwood City, CA 000 00000 00000000000 00000
0000000 Venture Capital-Backed Niel, Belgium 00 00000 00000000000 00000
0000000000 Formerly VC-backed Cambridge, MA 00 00000 000000&0 00000
00000000 Venture Capital-Backed Vienna, Austria 00.00 0000000000 00.00
0000000 0000000000 Venture Capital-Backed Utrecht, Netherlands 00 000.00 00000000000 000.00
You’re viewing 5 of 65 competitors. Get the full list »

Caelum Biosciences Executive Team (2)

Name Title Board Seat Contact Info
Susan Sobolov Ph.D Chief Operating Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Caelum Biosciences Board Members (12)

Name Representing Role Since
Harlan Weisman MD Self Board Member 000 0000
Lindsay Rosenwald MD Self Board Member 000 0000
Martin Goldman Caelum Biosciences Board Member 000 0000
Martine Zimmerman Caelum Biosciences Board Member 000 0000
Paul Brooke Self Chairman 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Caelum Biosciences Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Columbia Technology Ventures University Minority 000 0000 000000 0
To view Caelum Biosciences’s complete investors history, request access »